|

Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care

RECRUITINGN/ASponsored by Hospital de Clinicas de Porto Alegre
Actively Recruiting
PhaseN/A
SponsorHospital de Clinicas de Porto Alegre
Started2024-08-08
Est. completion2026-08
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07236879

Summary

This is a clinical trial to evaluate the effects of universal screening for diabetic retinopathy (DR) and diabetic macular edema (DME) using artificial intelligence (AI) in the interpretation of fundus photographs obtained by trained nursing assistant using a portable fundus camera in a primary care setting, compared with images obtained by the same method, but interpreted by ophthalmologists.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adults (\> 18 years old) diagnosed with diabetes mellitus who agree to participate in the study.

Exclusion Criteria:

* Any contraindication for pharmacological mydriasis (such as knowledge of having closed-angle glaucoma, pregnancy).
* Life expectancy less than 6 months

Conditions2

DiabetesDiabetic Retinopathy

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.